Company news
Fangzhou Inc. news in 2025
Fangzhou Inc.'s news releases, calls and decks from 2025, newest first.
Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management
November 27, 2025
Fangzhou Awarded “Golden Bull Award” for Leadership in AI-Powered Chronic Disease Management
November 8, 2025
Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE
November 7, 2025
Fangzhou’s “XingJie” LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations
November 2, 2025
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
October 29, 2025
Fangzhou Unveils “AI + Weight Management” Innovation at China’s Inaugural National-Level Weight Management Symposium in Beijing
October 22, 2025
Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care
September 26, 2025
Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025
September 17, 2025
Fangzhou Wins Gilead ‘Award of Excellence’ for AI-Driven Chronic Disease Management
September 17, 2025
Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management
September 14, 2025
Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions
September 10, 2025
Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research
September 3, 2025
Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand
August 27, 2025
Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management
July 18, 2025
Fangzhou Tops China's App Store Chart for Healthcare Apps
July 3, 2025
Fangzhou Showcases AI-Driven Healthcare Ecosystem at PHARMCHINA as China's Shift to Digital Medicine Accelerates
May 29, 2025
Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations
May 13, 2025
Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
May 5, 2025
Fangzhou at the Forefront of AI-Healthcare Push as China Issues Pharmaceutical Industry Digital Transformation Roadmap
April 29, 2025
Fangzhou Launches Partnership for "AI + Hepatitis Prevention & Control Training Center" at the Greater Bay Area International Liver Disease Forum
April 16, 2025
Fangzhou Presents AI-Driven Healthcare Ecosystem at Guangzhou Biotech Innovation Salon
April 13, 2025
Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models
April 9, 2025
Fangzhou Designated as a 2024 National High-Tech Enterprise Amid Record Growth
April 3, 2025
Fangzhou Inc. Named Among Guangzhou's Top AI Innovators for Intelligent Healthcare Platform
March 27, 2025
Fangzhou Inc. Partners with Tencent Health and Tencent Cloud to Accelerate Development of AI-Enabled Healthcare Services
March 26, 2025
Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation
March 23, 2025
Fangzhou Inc.'s H2H Smart Healthcare Platform Honored as one of Guangdong's Premier High-Tech Innovation Products
March 17, 2025
Fangzhou Inc. Announces Inclusion as a Constituent of the Hang Seng Composite Index
February 23, 2025
Fangzhou Inc. integrates DeepSeek open-source AI Model to enhance Internet healthcare
February 18, 2025